Intranasal delivery of biologics to the central nervous system.
By Jeffrey J. Lochhead, R. Thorne. Advanced Drug Delivery Reviews, 2012
1,097 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Pharmaceutical Science, Pharmacy
View Paper: https://www.semanticscholar.org/paper/0902586c31cb203dd9259d56744dbff1b21afa7b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Talbot
- A. Kanthasamy
- M. Desforges
- W. Hsu
- Philippe Dubeau
- A. Bourgouin
- T. Crowe
- M. Dubé
Citations in the corpus
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? (2019, background): “On the other hand, these viruses may also use other peripheral nerves like the trigeminal nerve, which possesses nociceptive neuronal cells present in the nasal cavity [64,65], or alternatively, the sensory fibers of the vagus nerve, which stems from the brainstem and innervates different organs of ”
- Evaluation of intranasal delivery route of drug administration for brain targeting. (2018, neutral): “The cavities are lined with a layer of mucosa, and the total area of both nasal cavities is ∼150–160 cm2 (Lochhead and Thorne, 2012; Mygind and Änggård, 1984; Mygind and Dahl, 1998).”
- Mechanism of intranasal drug delivery directly to the brain (2018, background): “3 h to diffuse from the nasal epithelium to the olfactory bulb [52].”